NCT04008797 2026-02-27
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Eisai Inc.
Phase 1/2 Active not recruiting
Eisai Inc.
Actuate Therapeutics Inc.
Ruhr University of Bochum
H. Lee Moffitt Cancer Center and Research Institute
Bayer
Bio-Cancer Treatment International Limited